#Diagnostic Radiopharmaceuticals and Contrast Media Market

[credenceresearchdotblog]

The global demand for medical imaging reagents was valued at USD 16251.2 Million in 2023 and is expected to reach USD 25646.4 Million in 2032, growing at a CAGR of 5.2% between 2024 and 2032.Medical imaging reagents are essential in modern healthcare, significantly enhancing the diagnostic accuracy and treatment efficacy of various diseases. These reagents, including contrast media, radiopharmaceuticals, and fluorescent dyes, are used to visualize structures and functions within the body, aiding in the early detection, diagnosis, and monitoring of diseases. The global medical imaging reagents market has seen substantial growth, driven by technological advancements, an aging population, and increasing prevalence of chronic diseases.

Browse the full report at https://www.credenceresearch.com/report/medical-imaging-reagents-market

Market Overview

The medical imaging reagents market encompasses a variety of products that improve the visibility of internal organs, tissues, and systems in imaging procedures. These reagents are used in various imaging modalities, including:

1. X-ray and Computed Tomography (CT) 2. Magnetic Resonance Imaging (MRI) 3. Nuclear Medicine Imaging (PET and SPECT) 4. Ultrasound 5. Optical Imaging

Each modality requires specific types of reagents to enhance image clarity and detail. The primary categories of imaging reagents are:

- Contrast Media: Used to enhance the contrast of structures or fluids within the body, making them more visible on imaging. - Radiopharmaceuticals: Radioactive compounds used in nuclear medicine to diagnose and treat diseases. - Fluorescent Dyes: Used in optical imaging to highlight specific areas of interest.

Key Drivers

1. Technological Advancements: Continuous innovations in imaging technologies and the development of new and improved reagents have significantly contributed to market growth. For example, advancements in MRI contrast agents have led to better image quality and reduced side effects. 2. Aging Population: The global increase in the elderly population has led to a higher incidence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders. This demographic shift has increased the demand for diagnostic imaging procedures.

3. Prevalence of Chronic Diseases: The rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular diseases, has driven the need for advanced diagnostic tools. Early diagnosis through imaging is crucial for effective treatment and management of these conditions.

4. Growing Awareness and Screening Programs: Increased awareness about the benefits of early diagnosis and the implementation of screening programs for various diseases have boosted the demand for imaging procedures, thereby driving the market for imaging reagents.

Market Segmentation

The medical imaging reagents market can be segmented based on product type, application, and geography.

1. Product Type: - Contrast Media - Radiopharmaceuticals - Fluorescent Dyes

2. Application: - Oncology - Cardiology - Neurology - Gastroenterology - Others

3. Geography: - North America - Europe - Asia-Pacific - Latin America - Middle East & Africa

Regional Insights

North America: Dominates the medical imaging reagents market, driven by advanced healthcare infrastructure, high healthcare expenditure, and a strong focus on research and development.

Europe: Follows closely, with significant investments in healthcare and increasing adoption of advanced imaging technologies.

Asia-Pacific: Expected to witness the fastest growth due to the rising healthcare expenditure, growing awareness about early diagnosis, and an increasing number of diagnostic imaging procedures.

Latin America and Middle East & Africa: These regions are also expected to see growth due to improving healthcare infrastructure and increasing adoption of advanced medical technologies.

Challenges and Opportunities

Challenges: - High Cost: The high cost of imaging procedures and reagents can be a barrier, especially in developing regions. - Side Effects: Some imaging reagents, particularly contrast media, can cause adverse reactions in patients, which can limit their use.

Opportunities: - Personalized Medicine: The growing trend of personalized medicine offers significant opportunities for the development of targeted imaging reagents. - Emerging Markets: Developing regions present substantial growth opportunities due to the expanding healthcare sector and increasing demand for advanced diagnostic tools.

Key Players

Bracco Spa

Lantheus Holdings Inc

General Electric Company

Siemens AG

Bayer AG

CMC Contrast AB

Thermo Fisher Scientific Inc

Merck & Co. Inc

Shimadzu Corporation

Koninklijke Philips N.V.

Others

Segmentation

By Type of Reagents

Contrast Agents

Iodinated Contrast Agents

Gadolinium-Based Contrast Agents

Barium-Based Contrast Agents

Microbubble Contrast Agents (used in ultrasound)

Nuclear Imaging Reagents

Technetium

Fluorine

Gallium

Thallium

Fluorescent Dyes

Bioluminescent Substrates

Others

By Imaging Modality

Computed Tomography (CT)

Magnetic Resonance Imaging (MRI)

Positron Emission Tomography (PET)

Ultrasound

X-ray

Nuclear Medicine

By Application

Cardiology

Oncology

Neurology

Orthopedics

Gastroenterology

Nephrology

Others

By End-User

Hospitals and Clinics

Diagnostic Imaging Centers

Research Institutes

Pharmaceutical and Biotechnology Companies

By Product Formulation

Ready-to-use Reagents

Dry Powder Reagents

Liquid Reagents

By Isotope

Radioactive Isotopes

Non-radioactive Isotopes

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

France

The U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/medical-imaging-reagents-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[ihealthcareanalyst]

New Post has been published on iHealthcareAnalyst, Inc. - Healthcare Market Research

iHealthcareAnalyst, Inc. announced Healthcare Market Research and Consulting Services -

iHealthcareAnalyst, Inc. News – 31-May-2016 – Missouri. U.S. – iHealthcareAnalyst, Inc., a global health care market research and consulting company announced syndicate, custom and consulting grade reports in the following categories: Animal Health Care, Biotechnology, Clinical Diagnostics, Health Care Informatics, Health Care Services, Medical Devices, Medical Equipment, and Pharmaceuticals.

Animal Health Care

Antiseptics and Disinfectants, Diagnostics and Therapeutics, Drugs, Vaccines, Feed Additives, Genetic Testing

Biotechnology

Bioinformatics, Biopharmaceuticals, Biologicals, Enzymes, Cell Culture, Media, Reagents, Consumables, Immunoassays, In Vitro Diagnostics, Microbiology Cultures, Microscopes and Cameras, Molecular Diagnostics, Next Generation Sequencing, Polymerase Chain Reaction, Stem Cells, etc.

Clinical Diagnostics

Autoimmune Diseases, Cancers, Cervical Cancer, Companion Cancers, Dermatology, Enteric Diseases, Hospital-acquired Infection, Lateral Flow Diseases, Noninvasive Prenatal, Preimplantation Genetic Diagnosis. Rapid Diagnostics, Respiratory Diseases, etc.

Health Care Informatics

Cloud Computing in Health Care, Electronic Health Records, Medical Device Sensors, Medical Robotic Systems, Microelectromechanical Systems, Mobile Health (mHealth), Population Health Management Solutions, Preventive Health Care Technologies and Services, Telehealth and Telemedicine, Biometric Systems, etc.

Health Care Services

Ambulance, Ambulatory Emergency Care, Biomedical Waste Management, Business Process Outsourcing, Clinical Laboratory Diagnostics, Cord Blood Banking, Geriatric Care, Health Care Contract Manufacturing, Home Health Care, Home Rehabilitation, Medical Tourism, Medical Transcription, Urgent Care Centers, Video Telemedicine, etc.

Medical Devices

Ablation Technologies, Acute Care Needleless Connectors, Anesthesia, Angioplasty Balloons, Atrial Fibrillation, Autoinjectors, Biopsy, Blood Flow Measurement, Blood Pressure Monitoring, Blood Processing, Bone Grafts and Substitutes, Bone Osteosynthesis, Breast Imaging, Breast Pumps, Cardiac Pacemakers, Cardiopulmonary Stress Testing, Compression Therapy, Contrast Media Injectors, Dental Prosthetics, Disposable Syringes, Gynecology, Implantable Drug Delivery, Interventional Cardiology, Medical Infection Control, Ophthalmology, Oxygen Therapy, Pain Management, Personal Mobility, Radiofrequency Ablation, Respiratory, Spinal Trauma, Ultrasound, Wearable Medicals, Wound Closure, etc.

Medical Equipment

Capnography, Casting and Splinting, Dental, Lyophilization, Medical Gases, Medical Imaging, Multiparameter Patient Monitoring, Operating Room, Orthodontics, Rental, Spectrometry, Surgical, etc.

Pharmaceuticals

Active Pharmaceutical Ingredients, Anti-Aging, Antibacterial, Breast Cancer, Collagen Peptides, Contraceptives, Diabetes, Dilated Cardiomyopathy, Dyslipidemia, Epigenetics, Erectile Dysfunction, Gelatin, Geriatric Medicines, Highly Potent API, Hospital Pharmaceuticals, Hospital-Acquired Infections, Hospital-Acquired Pneumonia, Hypertrophic Cardiomyopathy , Inhalation and Nasal Spray, Kidney Cancer, Liver Diseases, Mouth Ulcers, Non-Small Cell Lung Cancer, Oral Contraceptives, Organ Transplant Immunosuppressants, Osteoporosis, Pain Management, Parenteral Nutrition, Peptides, Pharmacovigilance, Primary Immunodeficiency Diseases, Pulmonary Arterial Hypertension, Radiopharmaceuticals, Smoking Cessation , Thyroid Gland Disorders, etc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company has published about 150+ reports covering 70+ companies and 20+ countries in Animal Health Care, Biotechnology, Clinical Diagnostics, Health Care Informatics, Health Care Services, Medical Devices, Medical Equipment, and Pharmaceuticals.

Read on Analyst Insights, Research Services, and About Us.

  - https://www.ihealthcareanalyst.com/ihealthcareanalyst-announced-health-care-market-research-analytics-services/

[researchreports-posts]

Diagnostic Radiopharmaceuticals & Contrast Media Market Size, Trends, Scope, Competitive Landscape and Forecast by 2027

Diagnostic Radiopharmaceuticals & Contrast Media Market: Introduction

Diagnostic radiopharmaceuticals are molecules containing a drug attached with a radioisotope targeted toward a certain tissue/organ for diagnosis as well as treatment of diseases such as cancer, cardiovascular diseases, and hyperthyroidism. Radiopharmaceuticals are being extensively used in a technique called molecular imaging…

[rohinic123-blog]

Diagnostic Radiopharmaceuticals & Contrast Media Market  to be at Forefront by 2027

Diagnostic Radiopharmaceuticals & Contrast Media Market: Introduction

Diagnostic radiopharmaceuticals are molecules containing a drug attached with a radioisotope targeted toward a certain tissue/organ for diagnosis as well as treatment of diseases such as cancer, cardiovascular diseases, and hyperthyroidism. Radiopharmaceuticals are being extensively used in a technique called molecular imaging as biomarkers for specific molecular procedures that determine the onset and/or growth of a disease.

Contrast media are used to improve the quality of medical imaging such as CT, PET/CT, MRI, and ultrasound. Their value has long been recognized by regular use in the radiology department across the world.

Planning To Lay Down Future Strategy? Request Brochure Of Diagnostic Radiopharmaceuticals & Contrast Media Market

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76337

Key Drivers and Restraints of Global Diagnostic Radiopharmaceuticals & Contrast Media Market

Technological advances leading to efficient workflow would increase acceptance of contrast media

Technological advances is one of the major drivers of contrast media. Over the years, contrast media injectors have evolved significantly, right from manual injection systems to automated versions. Majority of the market players focus on developing efficient injectors with enhanced capabilities such as control on the flow of contrast media, in-built patient safety, and cost reduction.

Other factors include increased use of data management systems and ensuring appropriate dosage in sync with fast medical imaging scanners. These features enable efficient workflows, which leads to increased acceptance of these contrast media. Some of the current trends in the design and performance of the contrast media injectors include switch from single to dual head injectors and prefilled & syringe less injectors.

Rise in awareness about accurate diagnosis

Increase in incidence of cancer and cardiovascular diseases across the globe asserts the need of an efficient diagnostic procedure that is highly accurate as well as cost-effective. Molecular imaging procedures using radioisotopes are gaining popularity primarily due to the ease of administration and high accuracy.

Every day over 100,000 diagnostic procedures are performed globally using radiopharmaceuticals. The Australian Nuclear Science and Technology Organisation (ANSTO) estimated that over 60 million doses of technetium-based radiopharmaceuticals alone were required globally for nuclear imaging and therapy in 2016.

To Obtain All-Inclusive Information On Forecast Analysis Of Diagnostic Radiopharmaceuticals & Contrast Media Market , Request A Discount

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=76337

Strict regulatory guidelines for production, storage, and usage

Radioisotopes, by default, carry the stigma of radiation and its ill effects. The fear of radioactivity among patients as well as hospital authorities is likely to affect the rate of uptake of radiopharmaceuticals. Consequently, the regulatory guidelines for production, transport, and storage of these molecules are quite stringent, involving strict manufacturing guidelines, stern regulatory processes for FDA approvals, supply chain efficiency, and safety handling measures.

Additionally, the apprehensions involved with radiopharmaceutical exposure and overdose of radiation are the key factors restraining the market

Insulin Infusion Pumps Segment to Dominate Global Market

In terms of product type, the global diagnostic radiopharmaceuticals & contrast media market can be classified into technetium (Tc-99m), thallium (Tl-201), gallium (Ga-67), iodine (I-123), rhenium (Re-186), yttrium (Y-90), fluorine-18 (18F-FDG), rubidium (Rb-82), and others

Based on application, the global diagnostic radiopharmaceuticals & contrast media market can be categorized into radiology, interventional radiology, interventional cardiology, and others

In terms of procedure, the global diagnostic radiopharmaceuticals & contrast media market can be split into X-ray/CT, magnetic resonance imaging (MRI), ultrasound, and others

Based on end-user, the global diagnostic radiopharmaceuticals & contrast media market can be divided into hospitals, research & academic institutes, diagnostic imaging centers, and others

North America to Dominate Global Diagnostic Radiopharmaceuticals & Contrast Media Market

In terms of region, the global diagnostic radiopharmaceuticals & contrast media market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa

North America accounted for the largest share of the global diagnostic radiopharmaceuticals & contrast media market in 2018. Consistent technological advances and rigorous research & development initiatives resulting in development of novel and effective diagnostic radiopharmaceuticals & contrast media drive the market in the region. Moreover, increase in preference for early diagnosis of several chronic ailments such as cardiac disorders and cancer contributed to the growth of the diagnostic radiopharmaceuticals & contrast media market in North America and Europe.

Asia Pacific is expected to be the fastest growing market due to increase in research & development activities, rise in patient population, and surge in health care expenditure

Leading Players Operating in Global Diagnostic Radiopharmaceuticals & Contrast Media Market

The global diagnostic radiopharmaceuticals & contrast media market was highly fragmented in 2018. Key players operating in the global diagnostic radiopharmaceuticals & contrast media market are:

NTP Radioisotopes SOC Ltd.

Nordion, Inc.

Lantheus Medical Imaging, Inc.

IBA Group a.s.

Medtronic

Eckert & Ziegler

Advanced Accelerator Applications

Medtron AG

Bayer

Mallinckrodt Pharmaceuticals

Bracco Imaging S.p.A.

More Trending Reports by Transparency Market Research –

Digital Pathology Market –

https://www.globenewswire.com/news-release/2019/02/01/1709009/0/en/Digital-Pathology-Market-to-reach-more-than-US-900-Million-by-2026-TMR.html

Hepatitis Therapeutics Market –

https://www.globenewswire.com/news-release/2019/02/04/1709736/0/en/Hepatitis-Therapeutics-Market-to-touch-US-25-197-2-million-by-2026-TMR.html

[famousobservationbouquetme]

Iodine Market Regional Outlook, Size, Share, Growth, Trends, Demand, Industry Analysis, and Key Player profile by 2023

Market Research Future has published a Cooked Research Report on the Global Iodine Market Research Report- Forecast to 2023

Iodine is a substrate extensively used in a range of applications, such as LCD polarizers, biocides, X-ray contrast media, animal nutrition, health nutrition, fluorochemicals, and pharmaceuticals, among others. As a result, Iodine invariably witnesses massive consumption & demand, garnering huge market prominence. Also, the Global Iodine Market has been growing dramatically over the past couple of years, addressing the augmented demand from the radiologists and others.

According to a leading research firm - Market Research Future (MRFR), the Global Iodine Market is expected to create a significantly large revenue pocket by 2023. In its recently published study, MRFR also asserts that the market would register a CAGR over 4.89% throughout the forecast period (2018 – 2023). Technological advancements in medical imaging technology & techniques and the burgeoning healthcare sector are some of the key driving forces pushing upmarket growth.

Besides, factors such as the increasing numbers of public as well as private diagnostic centers with improved diagnostic imaging services are fostering the market demand. Moreover, the rapidly growing contrast media market propel the market growth to an extent. Adversely, factors such as the high toxicity levels associated with Iodine might pose challenges to market growth.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6424

Nevertheless, the rise in the Iodine deficiency among people, especially the demographics of developing regions would support the growth of the market, creating a huge demand for health supplements.

Global Iodine Market – Competitive Landscape

Fiercely competitive, the Iodine Market appears to be fragmented due to the presence of numerous matured & small-scale players. To gain a considerably large share in the market, players initiate strategies such as mergers & acquisitions, expansion, collaboration, and product & technology launch. They invest heavily in R&D to develop a manufacturing technique that is entirely on a different level compared to their competition.

Industry, Innovation & Related News

February 11, 2019 --- Progenics Pharmaceuticals, Inc. (the US), an oncology company involved in the development of innovative medicines and imaging analysis technology used in the cancer treatments, announced the acquisition of a New Jersey-based manufacturing facility for AZEDRA® for cash consideration of USD 8 MN. The Company has also secured the long-term supply of Iodine necessary to produce both AZEDRA and 1095.

These strategic transactions extend Progenics’ leadership position in radiopharmaceuticals, establishing the infrastructure and manufacturing capabilities to label multiple types of isotopes, including iodine-131. With the acquisition, Progenics is building the capabilities to ensure the supply of AZEDRA.

AZEDRA is the first and only FDA approved radiopharmaceutical available for the treatment of ultra-rare cancers such as pheochromocytoma and paraganglioma. The site serves as the launch facility for AZEDRA and will also provide manufacturing support for the Company’s development stage radiopharmaceuticals, including 1095.

Major Players:

Key Players Leading the Global Iodine Market include Cosayach (Chile), Iofina (US), Deepwater Chemicals (US), Glide Chem Pvt. Ltd. (India), Calibre Chemicals Pvt. Ltd. (India), Itochu Chemical Frontier Corporation (Japan), Independent Iodine (Belgium), ISE Chemical Corporation (Japan), Zen Chemicals (India), JSC Isotope (Russia), Iochem Chemicals Corporation (US), ISR Holding (Azerbaijan), Eskay Iodine Private Limited (India), and GODO Shigen Co. Ltd. (Japan), among others.

Global Iodine Market – Segments

The report is segmented into three market dynamics to widen the scope of understanding,

By Type: Natural Brines and Nitrite Ores, among others.

By Application: LCD Polarizers, Biocides, X-ray Contrast Media, Animal Nutrition, Health Nutrition, Fluorochemicals, Pharmaceuticals, and Catalysts, among others.

By Regions: Europe, North America, Asia Pacific, and the Rest-of-the-World.

Global Iodine Market – Geographical Analysis

Europe is the largest region in the Global Iodine Market. The presence of a proliferating pharmaceutical industry and many industry leaders & market players drive the regional market growth. Heading with the resurging economy in the region, the Iodine Market in Europe would reach a valuation of USD 335.4 MN by 2023. Additionally, increasing healthcare expenditures alongside, the adoption of advanced technologies fosters the growth of the regional market.

The Iodine Market in the North American region accounts for the second-largest market, globally. Rapid growth in medical technologies and drug manufacturing units support the growth of the regional market. Besides, the presence of key pharma companies is boosting market demand. Moreover, increasing emphasis of Iodine manufacturers players in delivering cost-competitive and reliable product supply, foster the growth of the regional market. Heading with the same growth trends, the region is estimated to reach USD 214.1 MN by the end of 2023.

The Asia Pacific Iodine Market is lucrative, too, which is growing significantly. Rapidly increasing healthcare and pharmaceutical sector and the developing economy in the region is supporting the regional market growth. Developing markets in Japan, China, and India are further pushing up the increase in the regional market. Moreover, the rising population and spreading awareness towards the functionalities of contrast media drive the Iodine Market in the region.

Have Any Query? Ask Our Expert @ https://www.marketresearchfuture.com/enquiry/6424                                        

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact: Market Research Future +1 646 845 9312 Email: sales@marketresearchfuture.com

[healthy-insights]

Contrast Media/Contrast Agent Market Growth, Trends and Forecast up to 2024

Contrast medium or contrast agent is a substance used in medical imaging to enhance the contrast of fluids or structures inside the body. These help in better imaging of anatomical structures and organs by increasing the image contrast. Hence, these are helpful in diagnostic methods such as CT scan and in some critical surgeries. The global contrast media or contrast agent market is a fairly mature, and is expected to witness strong growth driven by increasing imaging diagnosis and surgical procedures. The contrast media or contrast agent market has evolved significantly over the last century. Initially, radiologists and practitioners used barium and iodine-based agents. Advancement in nanotechnology has enabled usage of gold nanoparticle along with radiopharmaceuticals.

Growth of The Contrast Media Or Contrast Agent Market is driven by increasing demand for image guided diagnostics and procedures, rising mortality of chronic diseases such as cancer, gastrointestinal disorders, and cardiac diseases, and growing demand for image guided surgical procedures. Growth of the market can also be attributed to factors such as increasing approvals for contrast agents and rising number of private and government diagnostic centers for improving diagnostic imaging services. Moreover, increasing research studies about applications of various contrast agents and strong pipeline products of the companies are projected to create new opportunities in the global contrast media or agent market.

 Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=876

 Advancement in technology and use of advanced techniques such as gas micro bubble technology in MRI imaging are likely to contribute to the growth of the market. Global reforms regarding better healthcare and radiopharmaceuticals, and increasing investments in the contrast media market are fueling market growth. However, sluggish economies, effecting sales of contrast media in medical reform, and fluctuating economies of regions like Europe may hamper the growth of the market.

The contrast media or contrast agent market can be segmented based on product, procedure, application, route of administration, indication, and region. The market can be segmented into barium-based contrast media, gadolinium-based contrast media, and iodinated contrast media. The iodinated contrast media segment accounts for the major market share due to high usage of iodinated agents in CT scan. Based on product type, the contrast media or agent market can be segmented into magnetic resonance imaging, ultrasound, X-ray/computed tomography (CT), and catheterization laboratory. In terms of application, the market can be categorized into interventional cardiology, radiology, and interventional radiology. Based on route of administration, the market can be segmented into injectable contrast media, oral contrast media, urethral contrast media, and rectal contrast media. The injectable contrast media segment accounted for the major share of the market due to increasing number of CT scans and MRIs performed. In terms of indication, the market has been segmented into nephrological disorders, neurological disorders, musculoskeletal disorders, gastrointestinal disorders, cardiovascular disorders, and oncology.

The global contrast media or contrast agent market has been segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are mature markets for contrast media and contrast agents. Strong infrastructure, improved MRI techniques in cardiovascular diseases, advanced cath-lab and reimbursement policies for contrast media or agent are the factors contributing to the high growth in these regions. Asia Pacific is expected to experience high growth due to increasing number of cardiac and other disorders, and advancement in technology. This region offers manufacturers lucrative opportunities for investment in the market.

 Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=876&ltype=S

 Major players in the contrast media or contrast agent market are GE Healthcare, Bracco Imaging S.p.A., Guerbet Group, Bayer HealthCare, CMC Contrast AB, Lantheus Medical Imaging, Daiichi Sankyo, nanoPET Pharma GmbH, and Subhra Pharma Private Limited, among others.

 About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

 US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

[zionmarketresearch]

Contrast Media/Contrast Agent Market: Increasing investments in the contrast media market and the reforms that are made in the radiopharmaceuticals and healthcare sector are boosting the market growth.

Contrast Media/Contrast Agent Market: Increasing investments in the contrast media market and the reforms that are made in the radiopharmaceuticals and healthcare sector are boosting the market growth.

Global Contrast Media/Contrast Agent Market: Overview

To enhance the contrast of the structures or fluids inside the body contrast medium or the contrast agent is used in the medical imaging. The anatomical organs and structures are imaged better as the image contrast is increased. Thus, it is very helpful in the diagnostic methods such as CT scan and also in some serious surgeries. The global…

[smitadeshmukh123]

Contrast Media/Contrast Agent Market Dynamics and Opportunities Report by Transparency Market Research

Contrast medium or contrast agent is a substance used in medical imaging to enhance the contrast of fluids or structures inside the body. These help in better imaging of anatomical structures and organs by increasing the image contrast. Hence, these are helpful in diagnostic methods such as CT scan and in some critical surgeries. The global contrast media or contrast agent market is a fairly mature, and is expected to witness strong growth driven by increasing imaging diagnosis and surgical procedures. The contrast media or contrast agent market has evolved significantly over the last century. Initially, radiologists and practitioners used barium and iodine-based agents. Advancement in nanotechnology has enabled usage of gold nanoparticle along with radiopharmaceuticals.

Growth of the contrast media or contrast agent market is driven by increasing demand for image guided diagnostics and procedures, rising mortality of chronic diseases such as cancer, gastrointestinal disorders, and cardiac diseases, and growing demand for image guided surgical procedures. Growth of the market can also be attributed to factors such as increasing approvals for contrast agents and rising number of private and government diagnostic centers for improving diagnostic imaging services. Moreover, increasing research studies about applications of various contrast agents and strong pipeline products of the companies are projected to create new opportunities in the global contrast media or agent market.

Obtain Report Details: http://www.transparencymarketresearch.com/global-contrast-media-contrast-agents.html

Advancement in technology and use of advanced techniques such as gas micro bubble technology in MRI imaging are likely to contribute to the growth of the market. Global reforms regarding better healthcare and radiopharmaceuticals, and increasing investments in the contrast media market are fueling market growth. However, sluggish economies, effecting sales of contrast media in medical reform, and fluctuating economies of regions like Europe may hamper the growth of the market.

The contrast media or contrast agent market can be segmented based on product, procedure, application, route of administration, indication, and region. The market can be segmented into barium-based contrast media, gadolinium-based contrast media, and iodinated contrast media. The iodinated contrast media segment accounts for the major market share due to high usage of iodinated agents in CT scan. Based on product type, the contrast media or agent market can be segmented into magnetic resonance imaging, ultrasound, X-ray/computed tomography (CT), and catheterization laboratory. In terms of application, the market can be categorized into interventional cardiology, radiology, and interventional radiology. Based on route of administration, the market can be segmented into injectable contrast media, oral contrast media, urethral contrast media, and rectal contrast media. The injectable contrast media segment accounted for the major share of the market due to increasing number of CT scans and MRIs performed. In terms of indication, the market has been segmented into nephrological disorders, neurological disorders, musculoskeletal disorders, gastrointestinal disorders, cardiovascular disorders, and oncology.

The global contrast media or contrast agent market has been segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are mature markets for contrast media and contrast agents. Strong infrastructure, improved MRI techniques in cardiovascular diseases, advanced cath-lab and reimbursement policies for contrast media or agent are the factors contributing to the high growth in these regions. Asia Pacific is expected to experience high growth due to increasing number of cardiac and other disorders, and advancement in technology. This region offers manufacturers lucrative opportunities for investment in the market.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=876

Major players in the contrast media or contrast agent market are GE Healthcare, Bracco Imaging S.p.A., Guerbet Group, Bayer HealthCare, CMC Contrast AB, Lantheus Medical Imaging, Daiichi Sankyo, nanoPET Pharma GmbH, and Subhra Pharma Private Limited, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

[healthy-insights]

Contrast Media/Contrast Agent Market: Key Players Profile And Market Analysis 2016 – 2024

Contrast medium or contrast agent is a substance used in medical imaging to enhance the contrast of fluids or structures inside the body. These help in better imaging of anatomical structures and organs by increasing the image contrast. Hence, these are helpful in diagnostic methods such as CT scan and in some critical surgeries. The global contrast media or contrast agent market is a fairly mature, and is expected to witness strong growth driven by increasing imaging diagnosis and surgical procedures. The contrast media or contrast agent market has evolved significantly over the last century. Initially, radiologists and practitioners used barium and iodine-based agents. Advancement in nanotechnology has enabled usage of gold nanoparticle along with radiopharmaceuticals.

Get Sample Copy of this Report @

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=876

Growth of the contrast media or contrast agent market is driven by increasing demand for image guided diagnostics and procedures, rising mortality of chronic diseases such as cancer, gastrointestinal disorders, and cardiac diseases, and growing demand for image guided surgical procedures. Growth of the market can also be attributed to factors such as increasing approvals for contrast agents and rising number of private and government diagnostic centers for improving diagnostic imaging services. Moreover, increasing research studies about applications of various contrast agents and strong pipeline products of the companies are projected to create new opportunities in the global contrast media or agent market.

Advancement in technology and use of advanced techniques such as gas micro bubble technology in MRI imaging are likely to contribute to the growth of the market. Global reforms regarding better healthcare and radiopharmaceuticals, and increasing investments in the contrast media market are fueling market growth. However, sluggish economies, effecting sales of contrast media in medical reform, and fluctuating economies of regions like Europe may hamper the growth of the market.

The contrast media or contrast agent market can be segmented based on product, procedure, application, route of administration, indication, and region. The market can be segmented into barium-based contrast media, gadolinium-based contrast media, and iodinated contrast media. The iodinated contrast media segment accounts for the major market share due to high usage of iodinated agents in CT scan. Based on product type, the contrast media or agent market can be segmented into magnetic resonance imaging, ultrasound, X-ray/computed tomography (CT), and catheterization laboratory. In terms of application, the market can be categorized into interventional cardiology, radiology, and interventional radiology. Based on route of administration, the market can be segmented into injectable contrast media, oral contrast media, urethral contrast media, and rectal contrast media. The injectable contrast media segment accounted for the major share of the market due to increasing number of CT scans and MRIs performed. In terms of indication, the market has been segmented into nephrological disorders, neurological disorders, musculoskeletal disorders, gastrointestinal disorders, cardiovascular disorders, and oncology.

View Report @ http://www.transparencymarketresearch.com/global-contrast-media-contrast-agents.html

The global contrast media or contrast agent market has been segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are mature markets for contrast media and contrast agents. Strong infrastructure, improved MRI techniques in cardiovascular diseases, advanced cath-lab and reimbursement policies for contrast media or agent are the factors contributing to the high growth in these regions. Asia Pacific is expected to experience high growth due to increasing number of cardiac and other disorders, and advancement in technology. This region offers manufacturers lucrative opportunities for investment in the market.

Major players in the contrast media or contrast agent market are GE Healthcare, Bracco Imaging S.p.A., Guerbet Group, Bayer HealthCare, CMC Contrast AB, Lantheus Medical Imaging, Daiichi Sankyo, nanoPET Pharma GmbH, and Subhra Pharma Private Limited, among others.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com